Re: Anke Richters, Marinde J. G. Bond, Hans M. Westgeest, et al. Development and External Validation of a New Prognostic Model for Metastatic Clear Cell Renal Cell Carcinoma: A Preregistered Analysis Using Data from Randomised Clinical Trials in the Checkpoint Inhibitor Era. Lancet Oncol 2026;27:1295–303
Elsevier ·
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Re: Anke Richters, Marinde J. G. Bond, Hans M. Westgeest, et al. Development and External Validation of a New Prognostic Model for Metastatic Clear Cell Renal Cell Carcinoma: A Preregistered Analysis Using Data from Randomised Clinical Trials in the Checkpoint Inhibitor Era. Lancet Oncol 2026;27:1295–303. // European Urology. – URL: https://www.sciencedirect.com/science/article/pii/S0302283826025078?dgcid=rss_sd_all
Re: Anke Richters, Marinde J. G. Bond, Hans M. Westgeest, et al. Development and External Validation of a New Prognostic Model for Metastatic Clear Cell Renal Cell Carcinoma: A Preregistered Analysis Using Data from Randomised Clinical Trials in the Checkpoint Inhibitor Era. Lancet Oncol 2026;27:1295–303. European Urology. https://www.sciencedirect.com/science/article/pii/S0302283826025078?dgcid=rss_sd_all
“Re: Anke Richters, Marinde J. G. Bond, Hans M. Westgeest, et al. Development and External Validation of a New Prognostic Model for Metastatic Clear Cell Renal Cell Carcinoma: A Preregistered Analysis Using Data from Randomised Clinical Trials in the Checkpoint Inhibitor Era. Lancet Oncol 2026;27:1295–303.” European Urology.
@article{article260681,
title = {Re: Anke Richters, Marinde J. G. Bond, Hans M. Westgeest, et al. Development and External Validation of a New Prognostic Model for Metastatic Clear Cell Renal Cell Carcinoma: A Preregistered Analysis Using Data from Randomised Clinical Trials in the Checkpoint Inhibitor Era. Lancet Oncol 2026;27:1295–303},
journal = {European Urology},
url = {https://www.sciencedirect.com/science/article/pii/S0302283826025078?dgcid=rss_sd_all}
}